TCP11L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.730000E-01
Normal-vs-Stage2
5.588200E-01
Normal-vs-Stage3
1.310240E-01
Normal-vs-Stage4
7.573600E-01
Stage1-vs-Stage2
4.552600E-01
Stage1-vs-Stage3
2.361000E-01
Stage1-vs-Stage4
8.233600E-01
Stage2-vs-Stage3
2.924400E-01
Stage2-vs-Stage4
7.596800E-01
Stage3-vs-Stage4
2.391400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.973400E-01
Normal-vs-AfricanAmerican
8.581800E-01
Normal-vs-Asian
2.134000E-01
Caucasian-vs-AfricanAmerican
4.076000E-01
Caucasian-vs-Asian
2.296600E-01
AfricanAmerican-vs-Asian
1.162230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.415800E-01
Normal-vs-Female
6.201800E-01
Male-vs-Female
6.964600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.832800E-01
Normal-vs-Age(41-60Yrs)
9.174200E-01
Normal-vs-Age(61-80Yrs)
5.104200E-01
Normal-vs-Age(81-100Yrs)
4.298400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.116600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.139400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.301400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.340100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.099970E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.168000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.477400E-01
Normal-vs-Daily Drinker
3.668000E-01
Normal-vs-Weekly Drinker
2.252400E-01
Normal-vs-Occasional Drinker
8.532200E-01
Normal-vs-Social Drinker
9.308200E-01
Non Drinker-vs-Daily Drinker
9.167400E-01
Non Drinker-vs-Weekly Drinker
6.924600E-01
Non Drinker-vs-Occasional Drinker
2.283200E-01
Non Drinker-vs-Social Drinker
1.935980E-01
Daily Drinker-vs-Weekly Drinker
7.873200E-01
Daily Drinker-vs-Occasional Drinker
2.490400E-01
Daily Drinker-vs-Social Drinker
1.882180E-01
Weekly Drinker-vs-Occasional Drinker
2.006800E-01
Weekly Drinker-vs-Social Drinker
1.389360E-01
Occasional Drinker-vs-Social Drinker
6.552200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.480200E-01
Normal-vs-Grade 2
5.898300E-02
Normal-vs-Grade 3
2.046100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.470800E-01
Grade 1-vs-Grade 3
2.589200E-01
Grade 1-vs-Grade 4
2.480200E-01
Grade 2-vs-Grade 3
6.134800E-01
Grade 2-vs-Grade 4
5.898300E-02
Grade 3-vs-Grade 4
2.046100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.477800E-01
Normal-vs-NonDiabetic
6.748600E-01
Diabetic-vs-NonDiabetic
5.470000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.224960E-01
Normal-vs-NoPancreatitis
6.763000E-01
Pancreatitis-vs-NoPancreatitis
1.123800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.489200E-01
Normal-vs-N1
5.625800E-01
N0-vs-N1
6.009800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.873200E-01
Normal-vs-TP53-NonMutant
9.610600E-01
TP53-Mutant-vs-TP53-NonMutant
1.006190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
